GlassScriptPhysician profile
Matthew Jude Mutter
NPI 1417272063
$7,402.32
in general payments reported to CMS, 2019-2025
19 companies · $1,193 in 2025
The $1,193 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,055 · 2020: $347 · 2021: $554 · 2022: $1,332 · 2023: $1,644 · 2024: $1,278 · 2025: $1,193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,323 · Travel and Lodging: $792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,322.97 |
| Travel and Lodging | $791.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,398.75 | 2019-2025 | Ams 700, General - Erectile Dysfunction, Spaceoar Vue System - 10ml |
| Coloplast Corp | $930.82 | 2021-2025 | Titan, Altis |
| Covidien LP | $175.00 | 2019 | |
| Axonics, INC. | $164.75 | 2022-2024 | Axonics |
| Cook Medical LLC | $138.15 | 2019-2025 | Cook, Litho 150 |
| Astellas Pharma US INC | $106.83 | 2019-2020 | |
| Abbvie INC. | $83.43 | 2023-2024 | |
| Immunitybio, INC. | $62.56 | 2025 | |
| Allergan, INC. | $57.22 | 2019-2020 | |
| Urogen Pharma, INC. | $53.55 | 2025 | |
| Rochester Medical Corporation | $48.77 | 2019 | |
| Medtronic USA, INC. | $38.86 | 2019-2020 | |
| Aytu Biopharma, INC. | $32.94 | 2019 | |
| Baxter Healthcare | $27.85 | 2020 | |
| Dendreon Pharmaceuticals LLC | $26.13 | 2025 | Provenge |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15.27 | 2022 | |
| Blue Earth Diagnostics | $14.87 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.49 | 2019 | |
| Pfizer INC. | $13.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Mutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.